![Liora Sklair-Tavron](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Liora Sklair-Tavron
Directeur des opérations chez Regentis Biomaterials Ltd.
Postes actifs de Liora Sklair-Tavron
Sociétés | Poste | Début | Fin |
---|---|---|---|
Regentis Biomaterials Ltd.
![]() Regentis Biomaterials Ltd. BiotechnologyHealth Technology Regentis Biomaterials Ltd. engages in the research and development of proprietary hydrogels for local repair of damaged cartilage and bone. Its product is GelrinC. The company was founded by Dror Seliktar and Tal Yehiel on September 1, 2004 and is headquartered in Or-Akiva, Israel. | Directeur des opérations | 01/03/2018 | - |
Historique de carrière de Liora Sklair-Tavron
Anciens postes connus de Liora Sklair-Tavron
Sociétés | Poste | Début | Fin |
---|---|---|---|
Bioblast Pharma Ltd.
![]() Bioblast Pharma Ltd. BiotechnologyHealth Technology Bioblast Pharma Ltd. operates as a clinical development-stage biopharmaceutical company. It focuses on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic diseases. The company also focuses on diseases with severe and debilitating manifestations, where the unmet medical need is clear, the biological mechanism of action is understood, and for which there is no satisfactory treatment. Its product candidates include Protein Stabilizing, Read-through, and Mitochondrial Protein Replacement Platforms. The company was founded by Dalia Megiddo and Ehud Moshe Gilboa on January 22, 2012 and is headquartered in Tel Aviv, Israel. | Conseiller Juridique Général | 01/03/2015 | - |
Formation de Liora Sklair-Tavron
Weizmann Institute of Science | Doctorate Degree |
Statistiques
Internationale
Israël | 4 |
Opérationnelle
General Counsel | 1 |
Doctorate Degree | 1 |
Chief Operating Officer | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Bioblast Pharma Ltd.
![]() Bioblast Pharma Ltd. BiotechnologyHealth Technology Bioblast Pharma Ltd. operates as a clinical development-stage biopharmaceutical company. It focuses on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic diseases. The company also focuses on diseases with severe and debilitating manifestations, where the unmet medical need is clear, the biological mechanism of action is understood, and for which there is no satisfactory treatment. Its product candidates include Protein Stabilizing, Read-through, and Mitochondrial Protein Replacement Platforms. The company was founded by Dalia Megiddo and Ehud Moshe Gilboa on January 22, 2012 and is headquartered in Tel Aviv, Israel. | Health Technology |
Regentis Biomaterials Ltd.
![]() Regentis Biomaterials Ltd. BiotechnologyHealth Technology Regentis Biomaterials Ltd. engages in the research and development of proprietary hydrogels for local repair of damaged cartilage and bone. Its product is GelrinC. The company was founded by Dror Seliktar and Tal Yehiel on September 1, 2004 and is headquartered in Or-Akiva, Israel. | Health Technology |
- Bourse
- Insiders
- Liora Sklair-Tavron
- Expérience